
    
      The study is an open label, non-randomized study designed to evaluate the diagnostic
      performance of SPECT CT. The study will consist of 3 cohorts, and a subset of the patients in
      cohort C will participate in a test-retest study, where the baseline SPECT/CT will be
      repeated.

      SPECT CT will be performed in all cohorts.

      Cohort A will evaluate SPECT CT by comparison to a Positron Emission Tomography (PET) scan
      using NaF.

      Cohort B will evaluate SPECT CT by comparison to 18F-DCFPyL PET/CT.

      Cohort C will evaluate SPECT CT by comparison to Whole Body Magnetic Resonance Imaging
      (WB-MRI).

      Eligible subjects will be enrolled in a non-randomized manner per the treating physician
      discretion.
    
  